Sanjay S. Reddy, MD, FACS
- Request Appointment
- Clinical Locations
- About
- Education and Training
- Patient Stories
- Research Profile
- Publications
- Ratings
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
About
Associate Professor, Department of Surgical Oncology
Attending Surgeon
Associate Program Director, Complex General Surgical Oncology Fellowship
Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Collaborating Member, Molecular Therapeutics
NCCN, Hepatobiliary Cancers Panel Member
Specialties
Treatment Focus
Hyperthermic intraperitoneal chemotherapy (HIPEC), gastric cancer, hepatobiliary cancer, general and minimally invasive surgery
Research Program
Treatment Philosophy
I decided to join the Fox Chase Cancer Center team in conquering cancer because I saw first-hand the dramatic difference we can make here. I decided to continue my training in Philadelphia after completing my general surgery residency in New York City, under the tutelage of my father, also a surgeon who spent many years treating cancer. I completed a two-year fellowship in complex surgical oncology at Fox Chase, working closely with various multidisciplinary teams in caring for patients with colorectal, liver, pancreatic and stomach cancers, in addition to melanoma and sarcomas. Being trained by leaders in the field, I had the unique opportunity to hone my skills and expertise, and apply them to my own clinical practice.
I have extensive training in traditional open surgery, as well as laparoscopic and robotic techniques, allowing me to offer individualized care to patients. I have particular interests in the management of sarcomas and colorectal, melanoma and pancreatic cancers. The implementation of minimally-invasive surgical techniques to the management of colorectal cancer is routinely offered at Fox Chase, and similar techniques are used to address pancreatic diseases. I also have a keen interest in the use of hyperthermic intraperitoneal chemotherapy (HIPEC), following cytoreductive surgery for cancer of the peritoneum, including appendix cancer, peritoneal mesothelioma and pseudomyxoma peritonei. In addition to this, there is a necessity to understand the benefit of, and perform further research, incorporating HIPEC in patients with colorectal and gastric cancers, which our team will explore further.
The benefit of an NCI-designated cancer center is that we are able to offer many innovative strategies in treating all types of cancers. Whether through a national clinical trial or particular surgical technique, we optimize patient care to the individual. I believe the physician-patient relationship is one of the foundations to building a plan to treat cancer, and I offer guidance through each stage of treatment. Medicine has always been a family-oriented field for me; with my father being a surgeon, and mother an anesthesiologist, I take great pride in offering compassion and honesty in formulating individualized treatment plans for every patient and his or her family.
Follow on Twitter: @FCCCSurgOnc
Education and Training
Educational Background
- Fellowship, Surgical Oncology Fellow, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA
- Residency, General Surgery, Beth Israel Medical Center, New York, NY
Certifications
- Complex Surgical Oncology, 2014
- American Board of Surgery, 2012
- Board Certified in Complex Surgical Oncology
Memberships
- American College of Surgeons
- Clinical Robotics Surgical Association
- Association for Academic Surgery
- American Society of Clinical Oncology
- Society of Surgical Oncology
- Society for Surgery of the Alimentary Tract
- Pancreas Club
- American Cancer Society- Metropolitan Philadelphia Chapter
Honors & Awards
- Top Physicians Under 40 2020, Pennsylvania Medical Society
- The John (Drew) Ridge Fellowship Award in Surgical Oncology, 2014
- Resident Teaching Award, Beth Israel Medical Center, Albert Einstein College of Medicine,2011
- Resident Teaching Award, St. Vincent's Medical Center, New York Medical College, 2010
- Harriet Gold Foundation, Scholar in Humanism Award, New York Medical College, 2010
- Academic Achievement in Molecular Cell Biology, St. Vincent's Medical Center, New York, NY, 2009
- Pi Kappa Alpha, Honors Society, 2002-2003
- University of Connecticut Dean's List, 2002-2003
Patient Stories
Trela Abad
Appendix Cancer
Trela Abad
Appendix Cancer
My cancer was found by accident! In 2018, I was suffering from chronic urinary tract infections (UTIs) and, after a variety of treatments, they weren’t getting better. My doctor suggested a CT scan of my lower abdomen, kidneys, and bladder to rule out anything serious.
The scan found a stone in my appendix and, after consulting with my doctor, I was advised to have the stone removed. About a month later, after I returned from a business trip, I went in for a routine appendectomy.
Andre Burke
Pancreatic Cancer
Andre Burke
Pancreatic Cancer
I often share my story and always encourage people who feel something is wrong to go to the doctor to get checked out. If you wait too long, it may be too late. I am thankful that I took that advice.
Jennifer O’Farrell
Colorectal Cancer
Jennifer O’Farrell
Colorectal Cancer
Unfortunately, because of COVID-19 precautions, my kids couldn’t be with me when I rang the bell to celebrate my last treatment in May. However, I was able to finish treatment with all the same nurses and staff who were there from the very beginning. They became like family to me.
James Brett
Pancreatic Cancer
James Brett
Pancreatic Cancer
I am 55 years old and a lot of my free time is spent acquiring cars, fixing them up, and moving on to the next one—that is, when I’m not working in my own auto body shop for my day job. My work is a big part of my life and I’m not yet ready to give it up, which is why when I was diagnosed with pancreatic cancer, I wasn’t sure what to think.
Pages
Research Profile
Research Program
Research Interests
My research interest for colorectal malignancies focuses on the use of national cancer databases to assess the accuracy of clinical staging, to see if this has improved over time, and to observe reporting standards between academic institutions versus other centers. As treatment of colorectal cancers involve multimodality planning, accurate clinical staging proves to be the foundation on how best to deliver care.
I also have a strong research interest in the vascular resectability staging of pancreatic cancer. Currently under review is our preoperative venous and arterial staging for borderline resectable pancreatic cancers and whether we are able to predict from preoperative imaging the likelihood of clear margin achievement and prognosis. As treatment of borderline resectable pancreatic cancer continues to evolve, accurate preoperative vascular resectability staging is imperative to assess and guide multimodality therapy.
Publications
Selected Publications
Tharmalingam S, Reddy S, Sharda P, Koch CA. Severe Hypocalcemia and transient hypoparathyroidism after hyperthermic intraperitoneal chemotherapy. Thieme Connect 2020;Aug 7
Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed
Barnica VH, Reddy SS, Wu H, Fang Z, Olszanski A, Farma JM. High Mitotic Rates in Patients with Cutaneous Melanoma. (Manuscript pending publication).
Reddy SS, Cooper HS, Ruth K, Chun YS, Watson JC, Hoffman JP. The Role of Adjuvant Chemoradiotherapy in Pancreatobiliary versus Intestinal Subtypes of Ampullary Cancers. Gastroenterology. Volume 144(5). 1107-1108. (Manuscript pending publication).
Reddy SS, Boukovalas S, Barnica V, Fang Z, Wu H, Farma JM. The Presence of Tumor Infiltrating Lymphocytes and their Role as a Prognostic Indicator for Melanoma. (Manuscript pending publication).
Reddy SS, Hoffman JP. Letter to the Editor Referencing, Kelly et al, Vein Involvement during Pancreaticoduodenectomy: is there a need for Redefinition of “Borderline Resectable Disease?” Journal of Gastrointestinal Surgery. February 2014.
Reddy SS, Leitman IM. Blood Transfusions in the Surgical Patient: A Gift of Life, but at What Cost? J Surg Res. Volume 181 (2): 216-218. May 2013.
Reddy SS, Leitman IM. Pharmacotherapy for Traumatic Spinal Cord Injury: The Science Behind the Promise. J Surg Res. Volume 181(2): 222-224. May 2013.
Reddy SS, Bloom ND. En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach. World J Surg Oncol. Volume 10(222): 1-6. October 2012.
Wayne MG, Reddy SS, Pacholka J, Yuan S, Levi G. Inflammatory Pseudotumor of the Spleen: Case Report. Journal of Solid Tumors. Volume 2(2): 43-46. April 2012.
Chander RK, Iskander M, Reddy SS, Kigongo S, Ingram M, Madlinger RV. Laparoscopic Dissection of Para-Aortic Mass. Surgical Science. August 2011.
Martins PN, Reddy SS, Martins AB, Facciuto ME. Follicular Dendritic Cell Sarcoma of the Liver: An Unusual Presentation of a Rare Tumor and Literature Review. Journal of Hepatobiliary Pancreat Dis Int. Volume 10: 443-5. August 2011.
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Associate Professor, Department of Surgical Oncology
Attending Surgeon
Associate Program Director, Complex General Surgical Oncology Fellowship
Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Collaborating Member, Molecular Therapeutics
NCCN, Hepatobiliary Cancers Panel Member
Treatment Focus
Hyperthermic intraperitoneal chemotherapy (HIPEC), gastric cancer, hepatobiliary cancer, general and minimally invasive surgery
Research Program
Treatment Philosophy
I decided to join the Fox Chase Cancer Center team in conquering cancer because I saw first-hand the dramatic difference we can make here. I decided to continue my training in Philadelphia after completing my general surgery residency in New York City, under the tutelage of my father, also a surgeon who spent many years treating cancer. I completed a two-year fellowship in complex surgical oncology at Fox Chase, working closely with various multidisciplinary teams in caring for patients with colorectal, liver, pancreatic and stomach cancers, in addition to melanoma and sarcomas. Being trained by leaders in the field, I had the unique opportunity to hone my skills and expertise, and apply them to my own clinical practice.
I have extensive training in traditional open surgery, as well as laparoscopic and robotic techniques, allowing me to offer individualized care to patients. I have particular interests in the management of sarcomas and colorectal, melanoma and pancreatic cancers. The implementation of minimally-invasive surgical techniques to the management of colorectal cancer is routinely offered at Fox Chase, and similar techniques are used to address pancreatic diseases. I also have a keen interest in the use of hyperthermic intraperitoneal chemotherapy (HIPEC), following cytoreductive surgery for cancer of the peritoneum, including appendix cancer, peritoneal mesothelioma and pseudomyxoma peritonei. In addition to this, there is a necessity to understand the benefit of, and perform further research, incorporating HIPEC in patients with colorectal and gastric cancers, which our team will explore further.
The benefit of an NCI-designated cancer center is that we are able to offer many innovative strategies in treating all types of cancers. Whether through a national clinical trial or particular surgical technique, we optimize patient care to the individual. I believe the physician-patient relationship is one of the foundations to building a plan to treat cancer, and I offer guidance through each stage of treatment. Medicine has always been a family-oriented field for me; with my father being a surgeon, and mother an anesthesiologist, I take great pride in offering compassion and honesty in formulating individualized treatment plans for every patient and his or her family.
Follow on Twitter: @FCCCSurgOnc
Education
Educational Background
- Fellowship, Surgical Oncology Fellow, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA
- Residency, General Surgery, Beth Israel Medical Center, New York, NY
Certifications
- Complex Surgical Oncology, 2014
- American Board of Surgery, 2012
- Board Certified in Complex Surgical Oncology
Memberships
- American College of Surgeons
- Clinical Robotics Surgical Association
- Association for Academic Surgery
- American Society of Clinical Oncology
- Society of Surgical Oncology
- Society for Surgery of the Alimentary Tract
- Pancreas Club
- American Cancer Society- Metropolitan Philadelphia Chapter
Honors & Awards
- Top Physicians Under 40 2020, Pennsylvania Medical Society
- The John (Drew) Ridge Fellowship Award in Surgical Oncology, 2014
- Resident Teaching Award, Beth Israel Medical Center, Albert Einstein College of Medicine,2011
- Resident Teaching Award, St. Vincent's Medical Center, New York Medical College, 2010
- Harriet Gold Foundation, Scholar in Humanism Award, New York Medical College, 2010
- Academic Achievement in Molecular Cell Biology, St. Vincent's Medical Center, New York, NY, 2009
- Pi Kappa Alpha, Honors Society, 2002-2003
- University of Connecticut Dean's List, 2002-2003
Research Profile
Research Interests
My research interest for colorectal malignancies focuses on the use of national cancer databases to assess the accuracy of clinical staging, to see if this has improved over time, and to observe reporting standards between academic institutions versus other centers. As treatment of colorectal cancers involve multimodality planning, accurate clinical staging proves to be the foundation on how best to deliver care.
I also have a strong research interest in the vascular resectability staging of pancreatic cancer. Currently under review is our preoperative venous and arterial staging for borderline resectable pancreatic cancers and whether we are able to predict from preoperative imaging the likelihood of clear margin achievement and prognosis. As treatment of borderline resectable pancreatic cancer continues to evolve, accurate preoperative vascular resectability staging is imperative to assess and guide multimodality therapy.
Publications
Selected Publications
Tharmalingam S, Reddy S, Sharda P, Koch CA. Severe Hypocalcemia and transient hypoparathyroidism after hyperthermic intraperitoneal chemotherapy. Thieme Connect 2020;Aug 7
Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed
Barnica VH, Reddy SS, Wu H, Fang Z, Olszanski A, Farma JM. High Mitotic Rates in Patients with Cutaneous Melanoma. (Manuscript pending publication).
Reddy SS, Cooper HS, Ruth K, Chun YS, Watson JC, Hoffman JP. The Role of Adjuvant Chemoradiotherapy in Pancreatobiliary versus Intestinal Subtypes of Ampullary Cancers. Gastroenterology. Volume 144(5). 1107-1108. (Manuscript pending publication).
Reddy SS, Boukovalas S, Barnica V, Fang Z, Wu H, Farma JM. The Presence of Tumor Infiltrating Lymphocytes and their Role as a Prognostic Indicator for Melanoma. (Manuscript pending publication).
Reddy SS, Hoffman JP. Letter to the Editor Referencing, Kelly et al, Vein Involvement during Pancreaticoduodenectomy: is there a need for Redefinition of “Borderline Resectable Disease?” Journal of Gastrointestinal Surgery. February 2014.
Reddy SS, Leitman IM. Blood Transfusions in the Surgical Patient: A Gift of Life, but at What Cost? J Surg Res. Volume 181 (2): 216-218. May 2013.
Reddy SS, Leitman IM. Pharmacotherapy for Traumatic Spinal Cord Injury: The Science Behind the Promise. J Surg Res. Volume 181(2): 222-224. May 2013.
Reddy SS, Bloom ND. En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach. World J Surg Oncol. Volume 10(222): 1-6. October 2012.
Wayne MG, Reddy SS, Pacholka J, Yuan S, Levi G. Inflammatory Pseudotumor of the Spleen: Case Report. Journal of Solid Tumors. Volume 2(2): 43-46. April 2012.
Chander RK, Iskander M, Reddy SS, Kigongo S, Ingram M, Madlinger RV. Laparoscopic Dissection of Para-Aortic Mass. Surgical Science. August 2011.
Martins PN, Reddy SS, Martins AB, Facciuto ME. Follicular Dendritic Cell Sarcoma of the Liver: An Unusual Presentation of a Rare Tumor and Literature Review. Journal of Hepatobiliary Pancreat Dis Int. Volume 10: 443-5. August 2011.
Related Articles
35 PATIENT COMMENTS
-
5.0
February 23, 2021
Courtesy was outstanding!
-
5.0
February 03, 2021
I have never been treated this well in any other hospital or healthcare facility. I'm always grateful for the care I received from my Dr.Reddy.
-
No Star Ratings Available
August 30, 2020
Dr. Reddy was honest and open concerning my issue.
-
5.0
August 22, 2020
Always a positive experience meeting with Dr. Reddy.
-
5.0
July 26, 2020
dr Reddy and Fox Chase have been wonderful!
-
5.0
July 10, 2020
I was very pleased with Dr. Reddy on my first appointment!
-
5.0
July 06, 2020
good experience
-
5.0
July 05, 2020
THE BEST DOCTOR I HAVE.
-
5.0
July 01, 2020
This visit was done virtually over the phone. Every thing went well. Dr Reddy is a genuinely very nice person and is concerned with his patients and their health. Could not have had a better doctor. Thank youasked for a better doctor
-
4.5
June 29, 2020
Good.
-
5.0
June 23, 2020
Dr. Reddy is an excellent doctor and surgeon.
-
5.0
June 21, 2020
Dr. Reddy was extremely kind, caring and perfectly knowledgeable about my condition.
-
5.0
June 08, 2020
Cancer surgery is very scary. Dr. Sanjay and his team made this a lot easier for me.
-
5.0
May 26, 2020
Dr. Reddy is the best!
-
5.0
May 22, 2020
excellent visit with Dr Reddy; excellent collaboration between Dr's at Fox Chase to develop treatment/surgery plans.
-
5.0
April 29, 2020
Dr. Reddy is a great doctor!!
-
5.0
April 23, 2020
Dr. Reddy as always was thoughtful, respectful and courteous through the duration of my visit.
-
5.0
April 23, 2020
I did not have a physical visit with Dr. Reddy because of the coronavirus. He called me on the phone which I appreciated very much. He and his staff are always very pleasant and professional. I am very fortunate and happy to have had Dr. Reddy as my doctor these last four and a half years. [...]
-
5.0
April 08, 2020
I have had appointments with doctor Reddy and Doctor [...]. Both of them have been great and they've shown a genuine concern for health.
-
5.0
March 30, 2020
Always a positive experience with Dr. Reddy [...].
LOAD MORE